Role of intranasal midazolam as a procedural sedative in children aged 6 months to 12 years: An open-label randomized controlled study

Journal Title: Indian Journal of Child Health - Year 2018, Vol 5, Issue 1

Abstract

Objectives: The objectives of the study were to evaluate the efficacy and the adverse effects of intranasal midazolam compared to intravenous (IV) midazolam for procedural sedation in children between 6 months and 12 years of age using the University of Michigan sedation scale. Design: Prospective open-label randomized controlled trial. Setting: Children requiring sedation for any invasive or non-invasive procedure in the Department of Paediatrics, between June 2012 and May 2014. Participants: A total of 246 children aged between 6 months and 12 years of age were enrolled and sequentially allocated into the study by computer-generated block randomization. Intervention: As per randomization, participants were administered intranasal or IV midazolam before the procedure. Procedure was done 5 min after IV and 15 min after intranasal administration. Main outcome measures: Sedation score was rated using the University of Michigan Sedation Score. The ease of performance, numbers of successfully completed procedures, and adverse effects were noted. Results: Intranasal midazolam provided better sedation scores (p<0.001) and ease of procedure scores (p=0.026) compared to IV, especially in the age group from 6 months to 6 years. Both groups gave comparable successful procedure completion rates. The most commonly encountered side effect with intranasal was nasal irritation (p<0.001). Conclusion: Intranasal midazolam provided significantly better sedation and ease of procedure scores when compared to IV, with fewer adverse effects. Hence, it can be put to use in resource-limited settings.

Authors and Affiliations

Swathy Subhash, Prameela Joji

Keywords

Related Articles

Antiepileptic drug compliance among caregivers of children with epilepsy: An observational cohort study

Background: Poor compliance with antiepileptic drugs (AEDs) not only increases morbidity and mortality rates among the children with epilepsy but it also leads to multiple hospital emergency room visits and enhanced heal...

Unintentional injuries in children at pediatric emergency center: A developing country perspective

Background: Unintentional injuries are important cause for childhood mortality and long-term morbidity. Developing countries accounts for majority of the childhood deaths due to unintentional injuries. Methods: This was...

A case of Canavan disease with normocephaly - A rare entity

Canavan disease (CD) is an autosomal recessive disorder with spongy degeneration of white matter of the brain. It typically presents with developmental delay, visual problems, and macrocephaly. Our patient presented with...

Comparison of 24% sucrose as analgesic during 2nd and 3rd diphtheria-pertussis-tetanus vaccinations with 1st diphtheria-pertussis-tetanus vaccination

Background: International clinical guidelines recommend oral sucrose to be given to relieve procedural pain in neonate. Objective: The aim of this is to study analgesic effect of 24% sucrose beyond neonatal age up to 4 m...

Gender outcome in children with disorders of sex development: A cryptic misfortune

Background: Disorders of sex development (DSD) are an important cause of management dilemma for a clinician, especially due to the difficulty in assigning a suitable sex to them. Not many studies are reported regarding t...

Download PDF file
  • EP ID EP460565
  • DOI -
  • Views 68
  • Downloads 0

How To Cite

Swathy Subhash, Prameela Joji (2018). Role of intranasal midazolam as a procedural sedative in children aged 6 months to 12 years: An open-label randomized controlled study. Indian Journal of Child Health, 5(1), 1-5. https://europub.co.uk/articles/-A-460565